Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Global High-Consequence Infectious Disease Readiness and Response: An Inventory of High-Level Isolation Units

Stern KL. et al, (2024), Health Security

Clinical Management of Hospitalized Patients With High-Consequence Infectious Diseases in England.

Alonso A. et al, (2024), Health security, 22, S50 - S65

Global Clinical Networking to Optimize the Clinical Management of High-Consequence Infectious Diseases.

Herstein JJ. et al, (2024), Health security, 22, S1 - S3

The worsening mpox outbreak in Africa: a call to action.

Kuppalli K. et al, (2024), The Lancet. Infectious diseases

Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms

Citarella BW. et al, (2024), Heliyon, 10, e29591 - e29591

Rapid emergence of transmissible SARS-CoV-2 variants in mild community cases.

Crone MA. et al, (2024), Microbiology spectrum

Mpox: The alarm went off. Have we gone back to sleep?

Olliaro P. et al, (2024), PLOS Neglected Tropical Diseases, 18, e0011871 - e0011871

Expanded Access Programme for the use of tecovirimat for the treatment of monkeypox infection: A study protocol for an Expanded Access Programme.

Bourner J. et al, (2024), PloS one, 19

Plasma steroid concentrations reflect acute disease severity and normalise during recovery in people hospitalised with COVID-19.

Devine K. et al, (2024), Clinical endocrinology

Evaluation of pragmatic oxygenation measurement as a proxy for Covid-19 severity

Swets MC. et al, (2023), Nature Communications, 14

Variability in clinical assessment of clade IIb mpox lesions

Jones B. et al, (2023), International Journal of Infectious Diseases, 137, 60 - 62

Major adverse cardiovascular events (MACE) in patients with severe COVID-19 registered in the ISARIC WHO clinical characterization protocol: A prospective, multinational, observational study.

Reyes LF. et al, (2023), Journal of critical care, 77

Mpox virus DNA contamination can still be detected by qPCR analysis after autoclaving.

Spencer A. et al, (2023), The Journal of hospital infection

COVID-19 risk mitigation in reopening mass cultural events: population-based observational study for the UK Events Research Programme in Liverpool City Region.

Burnside G. et al, (2023), Journal of the Royal Society of Medicine

Risk factors and vectors for SARS-CoV-2 household transmission: a prospective, longitudinal cohort study.

Derqui N. et al, (2023), The Lancet. Microbe, 4, e397 - e408

Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19

Kartsonaki C. et al, (2023), International Journal of Epidemiology, 52, 355 - 376

An opportunity seized: rapid clinical research provides insights into monkeypox virus dynamics and durations of infectiousness

Dunning J. and Ochu C., (2023), The Lancet Infectious Diseases, 23, 383 - 385

Randomised controlled trials for mpox in endemic countries.

Rojek A. et al, (2023), The Lancet. Infectious diseases, 23

Longitudinal mpox virus surface sampling in an outpatient setting.

Atkinson B. et al, (2023), J Hosp Infect

High consequence infectious diseases in Europe - the need for an expert clinical support service

Brantsæter A. et al, (2023), Population Medicine, 5, 116 - 116

MOSAIC: A cohort study of human mpox virus disease.

Pesonel E. et al, (2023), Wellcome open research, 8

Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study.

Fink DL. et al, (2022), The Lancet. Infectious diseases

Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts

Kundu R. et al, (2022), Nature Communications, 13

Tecovirimat for Monkeypox in Central African Republic under Expanded Access.

Mbrenga F. et al, (2022), The New England journal of medicine, 387, 2294 - 2295

Symptom‐based case definitions for COVID‐19: Time and geographical variations for detection at hospital admission among 260,000 patients

Baruch J. et al, (2022), Influenza and Other Respiratory Viruses, 16, 1040 - 1050

Monkeypox as an emerging infectious disease: the ophthalmic implications

Milligan AL. et al, (2022), British Journal of Ophthalmology

An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients

Gonçalves BP. et al, (2022), eLife, 11

Air and surface sampling for monkeypox virus in a UK hospital: an observational study

Gould S. et al, (2022), The Lancet Microbe

Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study

Reyes LF. et al, (2022), Critical Care, 26

Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses.

Needham EJ. et al, (2022), Brain : a journal of neurology

Evolutionary implications of human transmission of monkeypox: the importance of sequencing multiple lesions.

Ulaeto DO. et al, (2022), The Lancet. Microbe, 3, e639 - e640

Fitting to the UK COVID-19 outbreak, short-term forecasts and estimating the reproductive number

Keeling MJ. et al, (2022), Statistical Methods in Medical Research, 31, 1716 - 1737

Monkeypox: how will we know if the treatments work?

Rojek A. et al, (2022), The Lancet. Infectious diseases, 22, 1269 - 1270

Monkeypox treatment with tecovirimat in the Central African Republic under an Expanded Access Programme

Mbrenga F. et al, (2022)

Clinical features and management of human monkeypox: a retrospective observational study in the UK

Adler H. et al, (2022), The Lancet Infectious Diseases, 22, 1153 - 1162

Monkeypox virus contamination in an office-based workplace environment.

Atkinson B. et al, (2022), The Journal of hospital infection

Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study

Hakki S. et al, (2022), The Lancet Respiratory Medicine

Perpetual observational studies: new strategies to support efficient implementation of observational studies and randomized trials in infectious diseases.

Hassoun-Kheir N. et al, (2022), Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

Abbas A. et al, (2022), Scientific Data, 9

Broadening symptom criteria improves early case identification in SARS-CoV-2 contacts.

Houston H. et al, (2022), The European respiratory journal, 60

Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol

Knight SR. et al, (2022), Thorax, 77, 606 - 615

Exportation of Monkeypox Virus From the African Continent

Mauldin MR. et al, (2022), The Journal of Infectious Diseases, 225, 1367 - 1376

Distinct clinical symptom patterns in patients hospitalised with COVID-19 in an analysis of 59,011 patients in the ISARIC-4C study.

Millar JE. et al, (2022), Scientific reports, 12

Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study.

Närhi F. et al, (2022), The Lancet. Digital health, 4, e220 - e234

SARS-CoV-2 environmental contamination from hospitalised patients with COVID-19 receiving aerosol-generating procedures

Winslow RL. et al, (2022), Thorax, 77, 259 - 267

SARS-CoV-2 antigen lateral flow tests for detecting infectious people: linked data analysis

Deeks JJ. et al, (2022), BMJ, e066871 - e066871

Sustained Declines in Age Group-Specific Rotavirus Infection and Acute Gastroenteritis in Vaccinated and Unvaccinated Individuals During the 5 Years Since Rotavirus Vaccine Introduction in England

Gower CM. et al, (2022), Clinical Infectious Diseases, 74, 437 - 445

Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study

Singanayagam A. et al, (2022), The Lancet Infectious Diseases, 22, 183 - 195

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

Dejnirattisai W. et al, (2022), Cell, 185, 467 - 484.e15

Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study

Sullivan MK. et al, (2022), Nephrology Dialysis Transplantation, 37, 271 - 284

Load More

Include forthcoming?